Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control studyOwen A. Ross, Hiroyuki Tomiyama, Alexandra I. Soto‐Ortolaza et al.|The Lancet Neurology|2011Cited by 344
Locus for severity implicates CNS resilience in progression of multiple sclerosisAdil Harroud, Roland G. Henry, Pernilla Stridh et al.|Nature|2023Cited by 232
Brain atrophy in multiple sclerosis: mechanisms, clinical relevance and treatment optionsAthina Andravizou, Georgios M. Hadjigeorgiou, Efthimios Dardiotis et al.|Autoimmunity Highlights|2019Cited by 155
Determinants of cognitive performance and decline in 20 diverse ethno-regional groups: A COSMIC collaboration cohort studyDarren M. Lipnicki, Qi Gao, Steve R. Makkar et al.|PLoS Medicine|2019Cited by 142
Large-scale replication and heterogeneity in Parkinson disease genetic lociManu Sharma, Kuo-Chu Yueh, Jan Aasly et al.|Neurology|2012Cited by 132